LAMELLASOME-IPF-NA

N/A

Report date: 2022/02/08 10:39:44
NME

Base Information

Drug NameLAMELLASOME-IPF-NA
Drug Alias NameLAMELLASOME-IPF-NA
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLamellar Biomedical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLamellar Biomedical Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A